Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Sarah Cannon Research Institute is a leading oncology research organization conducting community-based clinical trials in Dallas. This Manager Clinical Research Support role oversees clinical support operations, regulatory compliance, and patient experience at the Dallas clinic.
You will manage a multidisciplinary team and optimize workflows while ensuring GCP/GLP compliance and SOP development aligned with corporate standards.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting‑edge research, SCRI is redefining cancer care around the world.
Our Manager Clinical Research Support will oversee and manage the clinical support operations ensuring regulatory compliance, operational excellence, and exceptional patient experience. Additionally, this position is responsible for managing and developing a multidisciplinary team of Lab Research Assistants, Clinical Research Assistants, Tissue Coordinators, Program Managers, Executive Support, Medical Assistants, and Front Desk Coordinators and for optimizing workflows. This position is onsite at our Dallas, TX clinic. Relocation assistance is not available.
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.